The Cancer Genome Atlas has completed its large scale genomic screening of tumor samples from 825 breast cancer patients. The Buck Institute, along with its partners at UC Santa Cruz, made a significant contribution to the landmark study which appears in Nature. Buck faculty Chris Benz, MD discusses findings that show that a particularly aggressive subtype of breast cancer, one that is very difficult to treat, shares many genetic features with a type of ovarian cancer. The study marks a major step toward the development of personalized medicine. The finding could have treatment implications for women for women who have this type of breast cancer. Benz is also a practicing oncologist at UC San Francisco.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…